Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families
暂无分享,去创建一个
A. Murakami | K. Yoshitake | A. Mizota | Takaaki Hayashi | S. Kameya | T. Iwata | T. Nakano | D. Kubota | S. Kikuchi | Kei Mizobuchi
[1] Ahmed M. Hagag,et al. Prospective deep phenotyping of choroideremia patients using multimodal structure-function approaches , 2020, Eye.
[2] K. Tsunoda,et al. Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings , 2020, Molecular genetics & genomic medicine.
[3] K. Tsunoda,et al. RDH5-Related Fundus Albipunctatus in a Large Japanese Cohort , 2020, Investigative ophthalmology & visual science.
[4] R. Sui,et al. CLINICAL CHARACTERISTICS AND MOLECULAR GENETIC ANALYSIS OF A COHORT OF CHINESE PATIENTS WITH CHOROIDEREMIA. , 2020, Retina.
[5] P. Melillo,et al. CHM/REP1 Transcript Expression and Loss of Visual Function in Patients Affected by Choroideremia. , 2019, Investigative Ophthalmology and Visual Science.
[6] K. Tsunoda,et al. High-Resolution Retinal Imaging Reveals Preserved Cone Photoreceptor Density and Choroidal Thickness in Female Carriers of Choroideremia. , 2019, Ophthalmic surgery, lasers & imaging retina.
[7] W. Feuer,et al. Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results. , 2019, American journal of ophthalmology.
[8] I. MacDonald,et al. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience. , 2018, American journal of ophthalmology.
[9] M.,et al. Changes [I] , 2018, The Complete Poems of William Barnes, Vol. 2: Poems in the Modified Form of the Dorset Dialect.
[10] K. Yamaki,et al. CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family , 2018, Ophthalmic genetics.
[11] Cristina Has,et al. Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .
[12] A. Bergen,et al. LONG-TERM FOLLOW-UP OF PATIENTS WITH CHOROIDEREMIA WITH SCLERAL PITS AND TUNNELS AS A NOVEL OBSERVATION , 2017, Retina.
[13] B. Wilhelm,et al. CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA. , 2018, Retina.
[14] R. Sui,et al. Rep1 copy number variation is an important genetic cause of choroideremia in Chinese patients , 2017, Experimental eye research.
[15] E. McDonagh,et al. Single‐base substitutions in the CHM promoter as a cause of choroideremia , 2017, Human mutation.
[16] Takaaki Hayashi,et al. Closure of a full‐thickness macular hole without vitrectomy in choroideraemia , 2017, Clinical & experimental optometry.
[17] Emily S. Charlson,et al. Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study. , 2017, Ophthalmology.
[18] K. Xue,et al. The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype , 2016, Investigative ophthalmology & visual science.
[19] Susan M. Downes,et al. A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia , 2016, Investigative ophthalmology & visual science.
[20] A. V. Cideciyan,et al. Visual Function and Central Retinal Structure in Choroideremia. , 2016, Investigative ophthalmology & visual science.
[21] G. Holder,et al. Visual Acuity after Retinal Gene Therapy for Choroideremia. , 2016, The New England journal of medicine.
[22] C. Rivolta,et al. A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice , 2016, PloS one.
[23] I. MacDonald,et al. Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy , 2016, Molecular genetics & genomic medicine.
[24] B. Wilhelm,et al. Multimodal assessment of choroideremia patients defines pre-treatment characteristics , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.
[25] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[26] F. Cremers,et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.
[27] G. Hall,et al. A clinical molecular genetic service for United Kingdom families with choroideraemia. , 2013, European journal of medical genetics.
[28] E. Traboulsi,et al. Choroideremia: A review of general findings and pathogenesis , 2012, Ophthalmic genetics.
[29] E. Traboulsi,et al. Choroideremia: Effect of age on visual acuity in patients and female carriers , 2012, Ophthalmic genetics.
[30] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[31] I. MacDonald,et al. The functional effect of pathogenic mutations in Rab escort protein 1. , 2009, Mutation research.
[32] M. Preising,et al. Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview , 2004, Ophthalmic genetics.
[33] H. Brunner,et al. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon , 2003, Human Genetics.
[34] D. K. Roberts,et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia , 2002, The British journal of ophthalmology.
[35] A. Murakami,et al. REP-1 gene mutations in Japanese patients with choroideremia , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.
[36] E. Kominami,et al. Visual impairment and REP-1 gene mutations in Japanese choroideremia patients. , 1999, Ophthalmic genetics.
[37] F. Cremers,et al. Cloning and characterization of the human choroideremia gene. , 1994, Human molecular genetics.
[38] M. Brown,et al. Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. , 1993, Science.
[39] E. Zrenner,et al. Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. , 1992, American journal of human genetics.
[40] A. Chapelle,et al. Aberrant splicing of the CHM gene is a significant cause of choroideremia , 1992, Nature Genetics.
[41] R. Nussbaum,et al. Isolation of a candidate gene for choroideremia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] F. Cremers,et al. Cloning of a gene that is rearranged in patients with choroideraemia , 1990, Nature.
[43] H. Palmer,et al. The Alberta Experience , 1982 .